Topics

Short-Course Rifamycin-Based Regimens Preferred for Latent TB

07:00 EST 14 Feb 2020 | Drugs.com

FRIDAY, Feb. 14, 2020 -- For treatment of latent tuberculosis infection (LTBI), short-course rifamycin-based regimens are preferred over longer-course isoniazid monotherapy, according to guidelines published in the Feb. 14 issue of the U.S. Centers...

Original Article: Short-Course Rifamycin-Based Regimens Preferred for Latent TB

NEXT ARTICLE

More From BioPortfolio on "Short-Course Rifamycin-Based Regimens Preferred for Latent TB"

Quick Search

Relevant Topic

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...